Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma In Situ of Breast
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma In Situ of Breast
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-08-28
DOI
10.3389/fonc.2017.00192
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Variability in Pathologists' Interpretations of Individual Breast Biopsy Slides: A Population Perspective
- (2016) Joann G. Elmore et al. ANNALS OF INTERNAL MEDICINE
- Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study
- (2016) Yasuaki Sagara et al. JOURNAL OF CLINICAL ONCOLOGY
- Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
- (2016) John F Forbes et al. LANCET
- Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness
- (2016) H. Gilbert Welch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tamoxifen Initiation After Ductal Carcinoma In Situ
- (2016) H. B. Nichols et al. ONCOLOGIST
- Overcalling low-risk findings: grouped amorphous calcifications found at screening mammography associated with minimal cancer risk
- (2016) Madoka Iwase et al. Breast Cancer
- Molecular phenotypes of DCIS predict overall and invasive recurrence
- (2015) K. E. Williams et al. ANNALS OF ONCOLOGY
- Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ
- (2015) G. Curigliano et al. ANNALS OF ONCOLOGY
- Population-based analysis of the impact and generalizability of the NSABP-B24 study on endocrine therapy for patients with ductal carcinomain situof the breast
- (2015) A. C. Lo et al. ANNALS OF ONCOLOGY
- A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone
- (2015) Eileen Rakovitch et al. BREAST CANCER RESEARCH AND TREATMENT
- Abstract P1-10-03: NSABP B-43 is unlikely to produce a cost-effective treatment strategy for HER2+ DCIS
- (2015) Michael D Alvarado et al. CANCER RESEARCH
- A Molecular Portrait of High-Grade Ductal Carcinoma In Situ
- (2015) Martin C. Abba et al. CANCER RESEARCH
- Addressing overtreatment of screen detected DCIS; the LORIS trial
- (2015) Adele Francis et al. EUROPEAN JOURNAL OF CANCER
- RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation
- (2015) Beryl McCormick et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ
- (2015) Yasuaki Sagara et al. JAMA Surgery
- Addressing overdiagnosis and overtreatment in cancer: a prescription for change
- (2014) Laura J Esserman et al. LANCET ONCOLOGY
- Influence of Study Features and Methods on Overdiagnosis Estimates in Breast and Prostate Cancer Screening
- (2013) Ruth Etzioni et al. ANNALS OF INTERNAL MEDICINE
- Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43
- (2013) Kalliopi P. Siziopikou et al. BREAST CANCER RESEARCH AND TREATMENT
- A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast
- (2013) L. J. Solin et al. JNCI-Journal of the National Cancer Institute
- Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery
- (2013) John R Benson et al. LANCET ONCOLOGY
- Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
- (2012) Archie Bleyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis
- (2011) Shi-Yi Wang et al. BREAST CANCER RESEARCH AND TREATMENT
- Impact of mammographic screening on the detection of good and poor prognosis breast cancers
- (2011) Laura J. Esserman et al. BREAST CANCER RESEARCH AND TREATMENT
- Characterizing the impact of 25 years of DCIS treatment
- (2011) Elissa M. Ozanne et al. BREAST CANCER RESEARCH AND TREATMENT
- Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS
- (2011) I. L. Wapnir et al. JNCI-Journal of the National Cancer Institute
- Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease
- (2010) S E Clark et al. BRITISH JOURNAL OF CANCER
- National Institutes of Health State-of-the-Science Conference Statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009
- (2010) C. J. Allegra et al. JNCI-Journal of the National Cancer Institute
- Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes
- (2010) B. A. Virnig et al. JNCI-Journal of the National Cancer Institute
- Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial
- (2010) Jack Cuzick et al. LANCET ONCOLOGY
- Preinvasive Breast Cancer
- (2009) Dennis C. Sgroi Annual Review of Pathology-Mechanisms of Disease
- Rethinking Screening for Breast Cancer and Prostate Cancer
- (2009) Laura Esserman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Local Excision Alone Without Irradiation for Ductal Carcinoma In Situ of the Breast: A Trial of the Eastern Cooperative Oncology Group
- (2009) Lorie L. Hughes et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started